Universidad de Castilla-La Mancha-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2023

  1. Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  2. Clinical considerations for the design of PROTACs in cancer

    Molecular Cancer, Vol. 21, Núm. 1

2021

  1. MZ1 co-operates with trastuzumab in HER2 positive breast cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

2019

  1. Poly(Cyclohexene phthalate) nanoparticles for controlled dasatinib delivery in breast cancer therapy

    Nanomaterials, Vol. 9, Núm. 9

  2. Screening and preliminary biochemical and biological studies of [RuCl(p-cymene)(N, N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models

    ACS Omega, Vol. 4, Núm. 8, pp. 13005-13014

  3. Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer

    Nanomaterials, Vol. 9, Núm. 12